Open AccessPB2081: TREATMENT PERSISTENCE AND ADHERENCE TO IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA: A GERMAN CLAIMS DATA ANALYSIS
Author(s) -
Buske C.,
Hess G.,
Bahar N.,
Yang K.,
Tang B.,
Imhof A.,
Vinz K.,
Herweijer E.,
Herold M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851156.61481.73
Subject(s) - ibrutinib , medicine , waldenstrom macroglobulinemia , medical prescription , diagnosis code , bruton's tyrosine kinase , tyrosine kinase , leukemia , chronic lymphocytic leukemia , pharmacology , population , environmental health , lymphoma , receptor